Is Chemomab Therapeutics Ltd. (CMMB) a Buy, Sell, or Hold?
NASDAQ : CMMB
Chemomab Therapeutics Ltd.
$1.52 USD
$0 (0.0%)
- Volume
- 72.78K
- Average Volume
- 123.1K
- Market Capitalization
- $9.36M
- P/E Ratio
- -1.38
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.84
- Year Low
- $1.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.31
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
3
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
7
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$125.27K
CMMB Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CMMB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Melincoff Gwen A | director | 2026-06-01 | 1.86 | 2026-06-03 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-05-29 | P-Purchase | 2.08 | 2026-06-01 |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-05-29 | P-Purchase | 2.05 | 2026-06-01 |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-05-29 | J-Other | 0 | 2026-06-01 |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-05-29 | J-Other | 0 | 2026-06-01 |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 5.94 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 5.16 | 2026-04-10 | |
| Mor George Adi | director, officer: Chief Executive Officer | 2026-03-18 | 3.2 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 0 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 6.8 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 3.2 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 109.04 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 14.12 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 6.48 | 2026-04-10 | |
| Darvish Nissim | director | 2026-03-18 | 3.44 | 2026-04-10 | |
| Darvish Nissim | director | 2026-06-01 | 5.24 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 0 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 52.8 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 109.04 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 14.12 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 6.48 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 2.96 | 2026-04-10 | |
| Cohen Neil Harris | director | 2026-03-18 | 6.16 | 2026-04-10 | |
| Cohen Neil Harris | director | 2027-03-16 | 2.14 | 2026-04-10 | |
| Moses Alan Charles | director | 2026-03-18 | 109.04 | 2026-04-10 | |
| Moses Alan Charles | director | 2026-03-18 | 14.12 | 2026-04-10 | |
| Moses Alan Charles | director | 2026-03-18 | 6.48 | 2026-04-10 | |
| Moses Alan Charles | director | 2026-03-18 | 2.96 | 2026-04-10 | |
| Moses Alan Charles | director | 2026-03-18 | 6.16 | 2026-04-10 | |
| Moses Alan Charles | director | 2027-03-16 | 2.14 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 39.31 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 8.44 | 2026-04-10 | |
| Fatal Sigal | officer: Chief Financial Officer | 2026-03-18 | 6.8 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 0 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 20.52 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 5.68 | 2026-04-10 | |
| Lawler John | officer: Chief Development Officer | 2026-03-18 | 2.2 | 2026-04-10 | |
| Quigley Jill M. | director | 2026-03-18 | 13 | 2026-03-31 | |
| Quigley Jill M. | director | 2026-03-18 | 6.8 | 2026-03-31 | |
| Quigley Jill M. | director | 2026-03-18 | 4 | 2026-03-31 | |
| Quigley Jill M. | director | 2026-06-16 | 5.24 | 2026-03-31 | |
| Nicaise Claude | director | 2026-03-18 | 109.04 | 2026-03-31 | |
| Nicaise Claude | director | 2026-03-18 | 14.12 | 2026-03-31 | |
| Nicaise Claude | director | 2026-03-18 | 6.48 | 2026-03-31 | |
| Nicaise Claude | director | 2026-03-18 | 2.96 | 2026-03-31 | |
| Nicaise Claude | director | 2026-03-18 | 6.16 | 2026-03-31 | |
| Nicaise Claude | director | 2027-03-16 | 2.14 | 2026-03-31 | |
| Darvish Nissim | director | 2023-06-14 | A-Award | 1.7 | 2023-07-05 |
| Darvish Nissim | director | 2021-04-19 | A-Award | 27.26 | 2023-07-05 |
| Darvish Nissim | director | 2016-10-28 | A-Award | 0.8 | 2023-07-05 |
| Darvish Nissim | director | 2023-03-16 | A-Award | 1.62 | 2023-07-05 |
| Darvish Nissim | director | 2022-03-07 | A-Award | 3.53 | 2023-07-05 |
| Quigley Jill M. | director | 2023-06-16 | A-Award | 1.71 | 2023-06-20 |
| Quigley Jill M. | director | 2022-06-16 | A-Award | 3.25 | 2023-06-20 |
| Fatal Sigal | officer: Chief Financial Officer | 2023-06-14 | A-Award | 1.7 | 2023-06-16 |
| Fatal Sigal | officer: Chief Financial Officer | 2022-11-08 | A-Award | 2.11 | 2023-06-16 |
| Fatal Sigal | officer: Chief Financial Officer | 2021-11-11 | A-Award | 9.83 | 2023-06-16 |
| Fatal Sigal | officer: Chief Financial Officer | 2023-06-01 | 0 | 2023-06-05 | |
| Fatal Sigal | officer: Chief Financial Officer | 2023-06-01 | 2.11 | 2023-06-05 | |
| Fatal Sigal | officer: Chief Financial Officer | 2023-06-01 | 9.83 | 2023-06-05 | |
| Nicaise Claude | director | 2023-03-16 | A-Award | 27.26 | 2023-03-23 |
| Nicaise Claude | director | 2023-03-16 | A-Award | 1.62 | 2023-03-23 |
| Nicaise Claude | director | 2023-03-16 | A-Award | 3.53 | 2023-03-23 |
| OrbiMed Israel GP Ltd. | director | 2023-01-03 | S-Sale | 3.34 | 2023-01-05 |
| OrbiMed Israel GP Ltd. | director | 2023-01-03 | S-Sale | 4.51 | 2023-01-05 |
| Mor George Adi | officer: Chief Scientific Officer | 2023-01-03 | S-Sale | 5.0268 | 2023-01-05 |
| Mor George Adi | officer: Chief Scientific Officer | 2023-01-03 | S-Sale | 5.0268 | 2023-01-05 |
| Mor George Adi | officer: Chief Scientific Officer | 2018-03-15 | A-Award | 0 | 2023-01-05 |
| Mor George Adi | officer: Chief Scientific Officer | 2016-10-28 | A-Award | 0 | 2023-01-05 |
| Cohen Neil Harris | director | 2022-11-16 | S-Sale | 2 | 2022-11-18 |
| Cohen Neil Harris | director | 2022-03-07 | A-Award | 3.53 | 2022-11-18 |
| Cohen Neil Harris | director | 2021-03-16 | A-Award | 13.17 | 2022-11-18 |
| Mor George Adi | officer: Chief Scientific Officer | 2022-11-16 | S-Sale | 2.0848 | 2022-11-17 |
| Mor George Adi | officer: Chief Scientific Officer | 2022-11-16 | S-Sale | 2.0848 | 2022-11-17 |
| Mor George Adi | officer: Chief Scientific Officer | 2018-03-15 | A-Award | 0 | 2022-11-17 |
| Mor George Adi | officer: Chief Scientific Officer | 2016-10-28 | A-Award | 0 | 2022-11-17 |
| Frankel Matthew Bejosa | officer: Chief Medical Officer | 2022-11-14 | 2.07 | 2022-11-15 | |
| Quigley Jill M. | director | 2022-06-16 | 3.25 | 2022-06-21 | |
| Marvin Donald | officer: Executive VP, CFO & COO | 2022-03-16 | A-Award | 0 | 2022-06-21 |
| Marvin Donald | officer: Executive VP, CFO & COO | 2022-03-16 | P-Purchase | 3.3 | 2022-06-21 |
| Maryles Joel Michael | director: | 2022-05-24 | A-Award | 0 | 2022-05-25 |
| Maryles Joel Michael | director: | 2022-05-24 | P-Purchase | 2.76 | 2022-05-25 |
| Cohen Neil Harris | director: | 2022-05-18 | P-Purchase | 3.19 | 2022-05-19 |
| Cohen Neil Harris | director: | 2022-05-18 | A-Award | 0 | 2022-05-19 |
| Maryles Joel Michael | director: | 2022-03-18 | A-Award | 0 | 2022-03-21 |
| Maryles Joel Michael | director: | 2022-03-18 | P-Purchase | 4.36 | 2022-03-21 |
| Marvin Donald | officer: Executive VP, CFO & COO | 2022-03-14 | A-Award | 0 | 2022-03-21 |
| Marvin Donald | officer: Executive VP, CFO & COO | 2022-03-14 | P-Purchase | 4 | 2022-03-21 |
| Pfost Dale R | officer: Chief Executive Officer | 2022-03-14 | A-Award | 0 | 2022-03-15 |
| Pfost Dale R | officer: Chief Executive Officer | 2022-03-14 | P-Purchase | 3.98 | 2022-03-15 |
| Cohen Neil Harris | director: | 2022-03-14 | A-Award | 0 | 2022-03-15 |